ING Groep NV Sells 41,844 Shares of Corteva, Inc. $CTVA

ING Groep NV reduced its position in shares of Corteva, Inc. (NYSE:CTVA) by 46.6% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 47,917 shares of the company’s stock after selling 41,844 shares during the quarter. ING Groep NV’s holdings in Corteva were worth $3,241,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in Corteva by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock worth $5,976,436,000 after buying an additional 373,680 shares during the period. Geode Capital Management LLC raised its stake in shares of Corteva by 1.4% during the second quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock valued at $1,339,651,000 after acquiring an additional 251,693 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of Corteva by 4.9% during the second quarter. Franklin Resources Inc. now owns 17,680,238 shares of the company’s stock worth $1,317,708,000 after purchasing an additional 824,451 shares during the period. Norges Bank acquired a new position in shares of Corteva during the second quarter worth $434,220,000. Finally, Bank of New York Mellon Corp grew its stake in shares of Corteva by 2.7% in the second quarter. Bank of New York Mellon Corp now owns 5,256,845 shares of the company’s stock worth $391,793,000 after purchasing an additional 138,484 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 1.2%

NYSE CTVA opened at $74.98 on Friday. The stock has a market capitalization of $50.67 billion, a P/E ratio of 47.46, a P/E/G ratio of 2.52 and a beta of 0.75. The business has a 50 day simple moving average of $69.67 and a 200 day simple moving average of $68.46. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. Corteva, Inc. has a one year low of $53.40 and a one year high of $77.41.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s payout ratio is 45.57%.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Royal Bank Of Canada raised their target price on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Oppenheimer set a $86.00 price target on Corteva in a research note on Thursday, February 5th. Citigroup lifted their price objective on Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and upped their target price for the company from $75.00 to $77.00 in a report on Thursday, February 5th. Finally, The Goldman Sachs Group restated a “buy” rating and set a $88.00 price target on shares of Corteva in a report on Thursday, February 5th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, Corteva has an average rating of “Moderate Buy” and a consensus price target of $82.20.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.